Fig. 2From: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsThe scenario I of no effect across all seven AEs under various flat incidence rate as dosage increases for eight arms. (The dashed line is the expected incidence rate for each AE)Back to article page